RS65511B1 - Farmaceutska kompozicija koja sadrži jedinjenje tetrahidropirazolopirimidinon - Google Patents
Farmaceutska kompozicija koja sadrži jedinjenje tetrahidropirazolopirimidinonInfo
- Publication number
- RS65511B1 RS65511B1 RS20240541A RSP20240541A RS65511B1 RS 65511 B1 RS65511 B1 RS 65511B1 RS 20240541 A RS20240541 A RS 20240541A RS P20240541 A RSP20240541 A RS P20240541A RS 65511 B1 RS65511 B1 RS 65511B1
- Authority
- RS
- Serbia
- Prior art keywords
- tetrahydropyrazolopyrimidinone
- compound
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 tetrahydropyrazolopyrimidinone compound Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019068419 | 2019-07-09 | ||
| PCT/EP2020/069230 WO2021005101A1 (en) | 2019-07-09 | 2020-07-08 | Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compound |
| EP20735633.8A EP3996682B1 (en) | 2019-07-09 | 2020-07-08 | Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS65511B1 true RS65511B1 (sr) | 2024-06-28 |
Family
ID=71409436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20240541A RS65511B1 (sr) | 2019-07-09 | 2020-07-08 | Farmaceutska kompozicija koja sadrži jedinjenje tetrahidropirazolopirimidinon |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20220265658A1 (sr) |
| EP (1) | EP3996682B1 (sr) |
| JP (1) | JP2022540780A (sr) |
| KR (1) | KR20220034821A (sr) |
| CN (1) | CN114096252A (sr) |
| AU (1) | AU2020312183A1 (sr) |
| BR (1) | BR112021024038A2 (sr) |
| CA (1) | CA3146386A1 (sr) |
| CL (1) | CL2022000040A1 (sr) |
| ES (1) | ES2974660T3 (sr) |
| HR (1) | HRP20240381T1 (sr) |
| IL (1) | IL289619A (sr) |
| MA (1) | MA56330B1 (sr) |
| MX (1) | MX2022000411A (sr) |
| PL (1) | PL3996682T3 (sr) |
| RS (1) | RS65511B1 (sr) |
| SG (1) | SG11202113254PA (sr) |
| TW (1) | TW202116323A (sr) |
| WO (1) | WO2021005101A1 (sr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3737684T (lt) | 2018-01-10 | 2022-12-27 | Idorsia Pharmaceuticals Ltd | 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ono dariniai ir susiję junginiai, kaip c5a receptoriaus moduliatoriai, skirti vaskulito ir uždegiminių ligų gydymui |
| EP4351515A1 (en) * | 2021-06-11 | 2024-04-17 | Universidade Da Beira Interior | Self-emulsifying composition, production methods and uses thereof |
| NL2028762B1 (en) * | 2021-07-16 | 2023-01-23 | Seranovo Holding B V | Micelle-generating formulations for enhanced bioavailability |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1715847A1 (en) * | 2003-12-23 | 2006-11-02 | Tibotec Pharmaceuticals Ltd. | Self-microemulsifying drug delivery systems of a hiv protease inhibitor6 |
| JP6417419B2 (ja) | 2013-09-04 | 2018-11-07 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 免疫調節剤として有用な化合物 |
| EP3363790B1 (en) | 2013-09-06 | 2020-02-19 | Aurigene Discovery Technologies Limited | 1,2,4-oxadiazole derivatives as immunomodulators |
| WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
| LT3737684T (lt) * | 2018-01-10 | 2022-12-27 | Idorsia Pharmaceuticals Ltd | 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ono dariniai ir susiję junginiai, kaip c5a receptoriaus moduliatoriai, skirti vaskulito ir uždegiminių ligų gydymui |
-
2020
- 2020-07-08 HR HRP20240381TT patent/HRP20240381T1/hr unknown
- 2020-07-08 JP JP2021577114A patent/JP2022540780A/ja active Pending
- 2020-07-08 ES ES20735633T patent/ES2974660T3/es active Active
- 2020-07-08 MA MA56330A patent/MA56330B1/fr unknown
- 2020-07-08 TW TW109122964A patent/TW202116323A/zh unknown
- 2020-07-08 PL PL20735633.8T patent/PL3996682T3/pl unknown
- 2020-07-08 MX MX2022000411A patent/MX2022000411A/es unknown
- 2020-07-08 EP EP20735633.8A patent/EP3996682B1/en active Active
- 2020-07-08 CN CN202080049413.2A patent/CN114096252A/zh active Pending
- 2020-07-08 SG SG11202113254PA patent/SG11202113254PA/en unknown
- 2020-07-08 KR KR1020227003926A patent/KR20220034821A/ko unknown
- 2020-07-08 WO PCT/EP2020/069230 patent/WO2021005101A1/en unknown
- 2020-07-08 AU AU2020312183A patent/AU2020312183A1/en active Pending
- 2020-07-08 CA CA3146386A patent/CA3146386A1/en active Pending
- 2020-07-08 RS RS20240541A patent/RS65511B1/sr unknown
- 2020-07-08 US US17/625,522 patent/US20220265658A1/en active Pending
- 2020-07-08 BR BR112021024038A patent/BR112021024038A2/pt unknown
-
2022
- 2022-01-04 IL IL289619A patent/IL289619A/en unknown
- 2022-01-07 CL CL2022000040A patent/CL2022000040A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11202113254PA (en) | 2021-12-30 |
| TW202116323A (zh) | 2021-05-01 |
| CA3146386A1 (en) | 2021-01-14 |
| CL2022000040A1 (es) | 2022-11-11 |
| EP3996682C0 (en) | 2024-02-28 |
| JP2022540780A (ja) | 2022-09-20 |
| AU2020312183A1 (en) | 2022-01-20 |
| BR112021024038A2 (pt) | 2022-01-18 |
| EP3996682B1 (en) | 2024-02-28 |
| KR20220034821A (ko) | 2022-03-18 |
| WO2021005101A1 (en) | 2021-01-14 |
| IL289619A (en) | 2022-03-01 |
| ES2974660T3 (es) | 2024-07-01 |
| PL3996682T3 (pl) | 2024-06-03 |
| US20220265658A1 (en) | 2022-08-25 |
| MX2022000411A (es) | 2022-02-10 |
| CN114096252A (zh) | 2022-02-25 |
| EP3996682A1 (en) | 2022-05-18 |
| HRP20240381T1 (hr) | 2024-06-07 |
| MA56330B1 (fr) | 2024-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201911928D0 (en) | Pharmaceutical compounds | |
| SG11202008732VA (en) | A pharmaceutical composition for anaemia | |
| IL289619A (en) | A pharmaceutical preparation containing a tetrahydropyrazolopyrimidine compound | |
| GB201911944D0 (en) | Pharmaceutical compounds | |
| GB201911517D0 (en) | Pharmaceutical composition | |
| GB201914910D0 (en) | Pharmaceutical compounds | |
| IL291570A (en) | Pharmaceutical preparations | |
| PL4076404T3 (pl) | Kompozycja farmaceutyczna pirazolu | |
| SG11202110315SA (en) | Pharmaceutical composition | |
| GB201915932D0 (en) | Pharmaceutical compounds | |
| GB201915273D0 (en) | Pharmaceutical compounds | |
| HUE064916T2 (hu) | Gyógyászati készítmény | |
| GB202114315D0 (en) | Pharmaceutical compound | |
| GB202104664D0 (en) | Pharmaceutical compound | |
| GB201914267D0 (en) | Pharmaceutical compounds | |
| GB201912067D0 (en) | Pharmaceutical compounds | |
| GB201911311D0 (en) | Pharmaceutical compounds | |
| GB2588172B (en) | A pharmaceutical composition comprising cannabinoid | |
| IL285728A (en) | Pharmaceutical composition | |
| GB201904339D0 (en) | Pharmaceutical compounds | |
| GB201918274D0 (en) | A composition | |
| GB201912686D0 (en) | Pharmaceutical composition | |
| GB201908003D0 (en) | Pharmaceutical composition | |
| GB201904771D0 (en) | New pharmaceutical compositions | |
| GB201904767D0 (en) | New pharmaceutical compositions |